Tag Archives:Parkinson’s disease
Can tremor, depression and progression of the Parkinson’s disease be suppressed simultaneously?
Truncation: A possible mechanism for diversity in Alpha-synuclein prion-like properties
Taking medicines the right way: what do people with Parkinson’s do?
Parkinson disease: a tale of three neurotransmitters
GSK-3 beta: a therapeutic target for Parkinson’s disease
Dementia with Lewy bodies and Parkinson’s disease-dementia: Current perspectives
How does Parkinson’s disease gets from your gut to your head?
呼吸困难在帕金森病:一个通讯器n problem, rarely diagnosed
帕金森病(PD)是第二个最common neurodegenerative disorder after Alzheimer’s disease. It is characterized by bradykinesia (slowness in movement) tremor, rigidity, and postural instability. Potential non-motor manifestations of PD include depression, anxiety, constipation, overactive bladder
Measuring motivation in Parkinson’s disease through the eyes response to money
TRIM32 and alpha-synuclein: a novel interplay in the neuronal system
‘HATs On’: A small molecule with big potential in epigenetic therapy for Parkinson’s disease
Promiscuous drugs exemplified by dopamine receptor ligands
A systems-level view of cerebellar function: The interplay between cerebellum, basal ganglia, and cortex
The environmental toxin BMAA detected in humans – Cause of neurodegenerative diseases?
Calcium disturbances in Parkinson’s disease
Targeted exercise intervention for bradykinesia in Parkinson’s disease
The right tool for the right job – it is brain surgery after all!
Parkinson’s alpha-synuclein assembles in the disease prone stable dimers
How antioxidants may have a pro-oxidant effect?
Parkinson disease and duodenal levodopa infusion: why patients withdraw the treatment?
Parkinson disease is a chronic and progressive movement disorder associated to degeneration of neurons in the brain, particularly in a region called substantia nigra. These neurons produce dopamine, a neural transmitter that is involved in the control